PP
CRBU icon

Paladin Partners’s Caribou Biosciences CRBU Stock Holding History

Paladin Partners’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-50
Closed -$88 – 205
2026
Q2 		$88 Hold
50
– – ﹤0.01% 212
2026
Q1 		$95 Hold
50
– – ﹤0.01% 208
2025
Q4 		$80 Buy
+50
New +$105 ﹤0.01% 214

Other funds holding CRBU

GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Paladin Partners's CRBU Position: Q3 2026 in Review

Paladin Partners sold out of Caribou Biosciences (CRBU) in Q3 2026, closing a stake of 50 shares — an estimated $88 sold.

Paladin Partners first reported a position in CRBU in Q4 2025 and held it in 3 quarters. The position peaked at $95 in Q1 2026. 3 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

  • Paladin Partners reported no remaining Caribou Biosciences position as of Q3 2026 after selling out during the quarter.
  • Paladin Partners sold 50 Caribou Biosciences shares in Q3 2026, an estimated $88.
  • Paladin Partners first reported a position in Caribou Biosciences in Q4 2025 and held it in 3 quarters.
  • Paladin Partners's Caribou Biosciences position peaked at $95 in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on Paladin Partners's 13F filing for Q3 2026, filed 6 Oct 2026.